rizatriptan has been researched along with Adverse Drug Event in 2 studies
rizatriptan: structure given in first source; RN given refers to benzoate
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rizatriptan is a selective agonist of the 5-hydroxytryptophan(1B/1D )receptors, with proven superiority over placebo, ergotamine and selected oral triptans, demonstrating a good profile of safety and tolerability." | 2.43 | Rizatriptan in migraine. ( Bigal, ME; Krymchantowski, AV, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Krymchantowski, AV | 1 |
| Bigal, ME | 1 |
1 review available for rizatriptan and Adverse Drug Event
| Article | Year |
|---|---|
Rizatriptan in migraine.
Topics: Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; E | 2005 |
1 other study available for rizatriptan and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |